Latest News about Market/Moving Exclusives
Recent news which mentions Market/Moving Exclusives
Telomir Pharmaceuticals Lead Drug Candidate Inhibits Tumor Growth In Aggressive Prostate Cancer Cells, Animal Study Shows
March 19, 2025
From Benzinga
From Benzinga
EXCLUSIVE: Indaptus Therapeutics Starts Phase 1 Combination Study of Decoy20 With BeiGene's Cancer Drug For Advanced Solid Tumors
March 18, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
EXCLUSIVE: Vivani Medical Announces First Implant In Early-Stage Human Study Of GLP-1 Implant For Obesity
March 13, 2025
From Benzinga
From Benzinga
EXCLUSIVE: AVID And Super League Bring Learning To Roblox, Helping Teens Build Real-World Skills Through Gaming
March 11, 2025
From Benzinga
EXCLUSIVE: Alzamend Neuro To Launch Phase 2 Study For Lead Drug For PTSD Patients In Late 2025 To Assess Lithium Delivery Benefits
March 11, 2025
From Benzinga
Cybersecurity Report Flags 7 Major Threats Against Governments, Corporations: Stocks And ETFs To Watch
March 11, 2025
From Benzinga
EXCLUSIVE: Botanical Synthesis Tech-Focused BioHarvest's First Synthetic Olive Cells Shows Reduced Fat Accumulation in Liver Cells
March 04, 2025
From Benzinga
EXCLUSIVE: MIRA Pharmaceuticals Kick Starts Human Trial In Israel For Ketamir-2 For Neuropathic Pain
March 04, 2025
From Benzinga
EXCLUSIVE: Eco Wave Power 2024 Earnings: 22% Topline Growth, Narrows Operating Losses
March 03, 2025
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.